CONTACT: Sean Lucey Intagras (813)226-1867 slucey@intagras.com www.intagras.com FOR IMMEDIATE RELEASE DATE: May 6, 2009 INTAGRAS POSTS Q1 EARNINGS GROWTH AND THE ADDITION OF CORNERSTONE THERAPEUTICS Tampa, FL - Intagras is pleased to announce Q1 2009 earnings growth in addition to re-signing Cornerstone Therapeutics, Inc. as the latest client to choose the SPL Portal SaaS offering. Intagras' 2009 first quarter earnings increased significantly over Q1 2008, the second best results for any quarter since the company was founded in March of 2005. "Steady growth is key for our company", stated CEO Craig Trautman. "Our corporate culture is one of responsible and sustainable growth that allow us to retain and attract the best resources and provide the highest level of quality to our clients." "Forecasts for Q2 look even better.", Trautman disclosed. "April was one of our best months ever, and the sales pipleine continues to provide new clients." Intagras continues to increase market share and grow revenue across the SaaS and IT consulting divisions of the company. Cornerstone will be taking advantage of the industry leadership position that Intagras has gained since the launch of SPL Portal in 2007. The SPL Portal solution is the market’s only Software as a Service (SaaS) application that meets the full requirements of the FDA’s electronic Structured Product Labeling (SPL) initiative. SPL Portal specifically addresses the new electronic listing and establishment registration requirements that will go into effect on May 31, 2009. SPL Portal allows clients to avoid expensive software implementation cost, benefit from a flexible, yet comprehensive service offering, and remain fully compliant with the current and ongoing FDA regulations. “The addition of Cornerstone as a SaaS solution client is a big win for us. The continued migration of customers to the SaaS model validates the approach is what the market needs." Craig Trautman – CEO, Intagras About Intagras Intagras is a Tampa-based consulting firm that focuses on the specific IT needs of companies within the Life Sciences industry as well as providing custom application development services across industries. About Cornerstone Therapeutics, Inc. Cornerstone is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription products for the respiratory market. Cornerstone’s development activities are typically late stage projects leading to short term commercialization opportunities. ~END~ If you would like more information about this topic or to schedule an SPL Portal demonstration, please contact Sean Lucey at (813)226-1867 or slucey@intagras.com